open access

Vol 12, No 1 (2017)
Evidence-based medicine — What's New?
Published online: 2017-03-03
Get Citation

Latest clinical trials from the birthplace of Jazz — Late Breaking Clinical Trials at AHA Scientific Sessions 2016 in New Orleans

Dawid Miśkowiec, Jarosław Damian Kasprzak
DOI: 10.5603/FC.2017.0017
·
Folia Cardiologica 2017;12(1):118-123.

open access

Vol 12, No 1 (2017)
Evidence-based medicine — What's New?
Published online: 2017-03-03

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Latest clinical trials from the birthplace of Jazz — Late Breaking Clinical Trials at AHA Scientific Sessions 2016 in New Orleans

Journal

Folia Cardiologica

Issue

Vol 12, No 1 (2017)

Pages

118-123

Published online

2017-03-03

DOI

10.5603/FC.2017.0017

Bibliographic record

Folia Cardiologica 2017;12(1):118-123.

Authors

Dawid Miśkowiec
Jarosław Damian Kasprzak

References (8)
  1. Hiatt WR, Fowkes FG, Heizer G, et al. EUCLID Trial Steering Committee and Investigators. Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Engl J Med. 2017; 376(1): 32–40.
  2. Nissen SE, Yeomans ND, Solomon DH, et al. PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016; 375(26): 2519–2529.
  3. Taggart DP, Altman DG, Gray AM, et al. ART Investigators. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016; 375(26): 2540–2549.
  4. Gibson CM, Pinto DS, Chi G, et al. Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral vitamin K antagonist treatment strategy. Circulation. 2017; 135(4): 323–333.
  5. Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016; 375(25): 2423–2434.
  6. Lewis GD, McNulty S, Hernandez AF, et al. Oral iron repletion effects on oxygen uptake in heart failure (IRONOUT HF). American Heart Association 2016 Scientific Sessions. November 16, 2016. New Orleans.
  7. Van Veldhuisen DJ, Ponikowski P, Metra M, et al. Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT-HF): A randomized controlled study. American Heart Association 2016 Scientific Sessions. November 16, 2016. New Orleans.
  8. Ray KK, Landmesser U, Leiter LA, et al. Insights from new therapeutic trials for lipids. ORION-1. Inclisiran inhibits PCSK9 synthesis by RNA interference. Planned interim analysis of a multi-center randomized controlled dose-finding trial. American Heart Association's Scientific Sessions 2016. November 12–16, 2016. New Orleans.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl